Department of Justice November 23, 2011 – Federal Register Recent Federal Regulation Documents

Classification of Two Steroids, Prostanozol and Methasterone, as Schedule III Anabolic Steroids Under the Controlled Substances Act
Document Number: 2011-30081
Type: Proposed Rule
Date: 2011-11-23
Agency: Drug Enforcement Administration, Department of Justice
This Notice of Proposed Rulemaking (NPRM) proposes to classify the following two steroids as ``anabolic steroids'' under the Controlled Substances Act (CSA): prostanozol (17[beta]-hydroxy- 5[alpha]-androstano[3,2-c]pyrazole) and methasterone (2[alpha],17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3 -one). The Drug Enforcement Administration (DEA) believes that this action is necessary to prevent the abuse and trafficking of these steroids. If the regulations are amended, these steroids will be listed as Schedule III controlled substances subject to the regulatory control provisions of the CSA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.